RNZ Health New Zealand removes new advice about Ehlers-Danlos syndromes and hypermobility spectrum disorder
The new guidance published last week, and described as a review of current evidence, has been criticised by patients and advocacy groups.
The new guidance published last week, and described as a review of current evidence, has been criticised by patients and advocacy groups.